Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction

Journal of Asthma

Volumn 34, Issue 1, 1997, Pages 53-59

  McDonald, C F ^a   Pierce, Rob J ^a   Thompson, P J ^b   Allen, D ^c   Bowler, S ^d   Breslin, A B X ^e   Bowes, G ^f   Saunders, N ^g   Murree Allen, K ^g   Frith, P ^h   Musk, A W ⁱ  

^a AUSTIN HEALTH   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d Mater Hospital   (Australia)

^e Department of Microbiology and Infectious Diseases   (Australia)

^f ALFRED HOSPITAL   (Australia)

^g ROYAL NEWCASTLE HOSPITAL   (Australia)

^h REPATRIATION GENERAL HOSPITAL   (Australia)

ⁱ SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Bambuterol; Effect side effect ratio; Elderly patients; Oral agonists; Reversible COAD; Terbutaline

Indexed keywords

BAMBUTEROL; BRONCHODILATING AGENT; TERBUTALINE;

ADULT; AGED; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREMOR;

EID: 0031051895     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909709071203     Document Type: Review

References (8)

1. Vilsvik JS, Langaker O, Persson G, Ringdal N, Kvelstad G, Schaanning J, Kvelstad G, Svensson K, Holthe S, Soliman S: Bambuterol: A new long acting bronchodilating prodrug. Ann Allergy 66:315-319 (1991).
2. Van den Berg W, Alanko K, Sahlstrom K, Jarvinen M, Mikkola E, Jansson C: Bambuterol once every evening 10 and 20mg compared with terbutaline 5mg three times daily. Eur Respir J 2(Suppl 8):8125 (1989) (abstract).
3. Persson G, Pahlm O: Efficacy and safety of bambuterol once daily in comparison with terbutaline t.i.d. clin Exp Allergy 20(Suppl 1):35 (1990) (abstract).
4. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax 42:773-778 (1987).
5. Larsen K, Schmekel B: Tremor in healthy volunteers after bambuterol and terbutaline CR-tablets. Eur J Clin Pharmacol 45:303-305 (1993).
6. Sitar DS, Aoki FY, Warren CP, Knight A, Grossman R, Alexander M, Soliman S: A placebo-controlled dose-findings study with bambuterol in elderly patients with asthma. Chest 103:771-776 (1993).
7. Astra Draco AB: Pharmakokinetics of once-daily bambuterol given in solutions of 3 different strengths and in plain tablets. Internal report 843-CR-2011.
8. Lisi DM: Muscle spasms and creatine phosphokinase elevation following salbutamol administration. Eur Respir J 2(1):98 (1989).